Bioequivalence Study on Pseudoephedrine HCl 120 mg ER Tablets Under Fasting Conditions

• Status: Completed
• Trial end date: 2004-12-01

Summary

Compare bioavailability of Pseudoephedrine hydrochloride extended release tablets (Ranbaxy Laboratories Limited) against reference product Sudafed ® 12-hour tablets 120 mg (Warner-Lambert) under fasting conditions.

• Phase: N/A

Details

• Lead Sponsor: Ranbaxy Laboratories Limited
• Treatments: Ephedrine; Pseudoephedrine